Digoxin in the elderly: pharmacokinetic consequences of old age.
about
Improving drug therapy in the elderly.The need for reassessment of digoxin prescribing for the elderlyThe effect of ageing on the disposition of nifedipine and atenololThe geriatric population and psychiatric medicationAge-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine.Use of antiarrhythmic drugs in elderly patientsThe pharmacokinetics of oxypurinol in people with gout.Complete heart block presenting as intermittent delirium: case report and review of the literature on cardiac disease in the elderly.Prescribing for older adults.Pharmacokinetic considerations for digoxin in older people.Is antiarrhythmic treatment in the elderly different? a review of the specific changes.Drug therapy in the elderly. How to achieve optimum results.Prescribing for the elderly. Part I: Sensitivity of the elderly to adverse drug reactions.Drug therapy in the elderly.Digoxin use in the elderly.Pharmacology and aging.Atrial fibrillation in older inpatients: are there any differences in clinical characteristics and pharmacological treatment between the frail and the non-frail?Aging and pharmacology.Accidental Intrathecal Administration of Digoxin in an Elderly Male with End-Stage Renal Disease.Verapamil disposition and cardiovascular effects in elderly patients after single intravenous and oral doses.Polypharmacy in the Elderly: Drug reactions and interaction in the aged.Pharmacokinetics of azapropazone in the elderlyAge-related changes in the pharmacokinetics and pharmacodynamics of nifedipine.Theophylline kinetics in relation to age: the importance of smoking.Atrial fibrillation in the elderly: a review.Beers-Fick criteria and drugs available through the Farmácia Dose Certa program.Pharmacokinetics of drugs in the elderly.
P2860
Q33607405-5955F139-8CD6-4E15-A3E7-A1BF1338DBCCQ34397449-B9418B10-868A-4C5B-BB7C-64EAD792A9FEQ34417199-F3C13789-FE4E-476B-8159-D175B0BBB346Q34543911-C5AE9688-87B2-46EE-9649-5D3F308EF0A0Q35608904-D0BE499C-1E2A-496C-9A07-D845354ED970Q35803612-53E12DDE-8612-441F-9ABD-2315187B8B23Q36077245-56769EF3-E12F-402B-A76E-C53DD9373DA6Q36336035-31D5A13A-92AC-47CA-A48A-49B90E236E9BQ36339974-10DB51BD-A383-4580-8EB5-1C488BF7D326Q37900254-B64F1843-888F-4428-B978-854B68681522Q37902523-E439907D-87BE-4179-8116-8A55DFC3C912Q37910895-40C066D8-9ED5-4F89-8046-6A8F754E650EQ38621436-255B69CE-37B4-4036-B9F2-9630FA8976B0Q39627241-D498A1BD-CABD-4781-AB7B-CF52D1B976E2Q40077731-9DF3B94D-8947-49F1-A55A-ED9E9EA78788Q40326065-1B8DA5EB-8A08-47EF-B794-EDA3D65E35DBQ40326082-7C61CA63-D1F8-4D76-AC11-30E745C466B4Q41341553-07F6CE14-CB02-4AFA-8E5D-91676C17448AQ41605760-F758962A-4EA7-45CD-A120-5648BD2562D8Q41623047-D21CFCDA-1E2B-442A-9B69-6E79DFB79646Q41816741-99C8ED0B-127A-41D0-9DE9-5A8CE1E12126Q41965300-9FCE65EF-E9B6-4120-A39F-2922E64F1C32Q42739047-CC671E1F-4359-4536-BF21-AECCAD93AE3FQ43229081-917117F3-E163-47AA-AD00-7ACDA2DA0C29Q43243670-D71F769A-315F-4813-A084-437119CAAA8AQ51026059-AD199FEC-AC83-415A-933E-FA841649C17EQ51807767-5D4E03A5-661D-4698-A867-F045D979F099Q55434768-84FB273E-5C41-4B18-834B-E282D74996CA
P2860
Digoxin in the elderly: pharmacokinetic consequences of old age.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Digoxin in the elderly: pharmacokinetic consequences of old age.
@en
type
label
Digoxin in the elderly: pharmacokinetic consequences of old age.
@en
prefLabel
Digoxin in the elderly: pharmacokinetic consequences of old age.
@en
P2093
P356
P1476
Digoxin in the elderly: pharmacokinetic consequences of old age.
@en
P2093
P304
P356
10.1002/CPT1979256772
P407
P577
1979-06-01T00:00:00Z